Skip Over Navigation Links

Research Network

The NIH Pharmacogenomics Research Network (PGRN) is a nationwide collaborative of scientists focused on understanding how a person’s genes affect his or her response to medicines. Funded since 2000, the network now includes 14 scientific research projects and seven network resources.

Upon renewal of this initiative in 2010, NIH Director Francis S. Collins, M.D., Ph.D. said “Thanks to breakthroughs in genome sequencing technologies and our growing understanding of genetic variation among individuals, there has never been a better time to propel the field of pharmacogenomics. Through these studies, we are moving closer to the goal of using genetic information to help prescribe the safest, most effective medicine for each patient.”


PGRN Research Groups, 2010-present

PGRN Network Resources, 2010-present

PGRN Partners, 2010-present



Vision and Mission

Vision and Mission 2010-present

Past Mission and Goals Statements


Present Organization Structure

Past Organizational Structures

Past Advisors


Network Members’ Publications Link to external Web site

Network-wide Publications


Request for Information: Soliciting Input on Current Needs in Pharmacogenomics Research, 2008

Graphics, 2000-2005

Reports, 1998-2004

Meetings, 1998-2004

Related Information

What to Expect From the Pharmacogenomics Research Network Link to external Web site
2011 article in Clinical Pharmacology & Therapeutics
By Rochelle M. Long and Jeremy M. Berg
This page last reviewed on August 19, 2011